NCT01235468 Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB) Status WITHDRAWN Phase PHASE1
NCT01172132 The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH" Status COMPLETED Phase N/A
NCT01168882 Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies Status WITHDRAWN Phase PHASE1
NCT01162096 Reduced Intensity Haploidentical Transplant for Hematological Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT01139164 Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3) Status TERMINATED Phase PHASE2
NCT01069887 A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell Transplant Status COMPLETED Phase N/A
NCT01060462 Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients Status COMPLETED Phase N/A
NCT00892502 Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? Status COMPLETED Phase NA
NCT00886522 Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies Status COMPLETED Phase PHASE2
NCT00884364 Exercise During Chemotherapy for Patients With Hematological Malignancies Status UNKNOWN Phase PHASE3
NCT00876148 Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting Status COMPLETED Phase N/A
NCT00841724 Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies Status COMPLETED Phase PHASE2
NCT00824993 Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients Status COMPLETED Phase PHASE3
NCT00788684 Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers Status COMPLETED Phase PHASE1
NCT00603954 Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings Status COMPLETED Phase PHASE2
NCT00580450 Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies Status UNKNOWN Phase PHASE1/PHASE2